Cadila Pharmaceuticals
Search results
A global lifesciences company driven by the purpose of delivering care and nurturance for the patients, backed by the power of innovation, science and cutting edge technology. With these attributes close to our heart, we wish to make a meaningful difference in serving patients and communities.
Sep 13, 2022 · From formulations to active pharmaceutical ingredients and animal healthcare products to wellness products, Zydus has earned a reputation amongst Indian pharmaceutical companies for providing comprehensive and complete healthcare solutions.
2 days ago · New Delhi, Oct 2 (PTI) Zydus Lifesciences on Wednesday said it has received approval from the US health regulator to produce a generic prostate cancer treatment drug. The company has received tentative approval from the US Food and Drug Administration (USFDA) to manufacture Enzalutamide tablets (40 mg and 80 mg), the drug maker said in a regulatory filing.
1 day ago · Zydus Lifesciences: The company has received tentative approval from the US Food and Drug Administration (USFDA) to manufacture Enzalutamide tablets (40 mg and 80 mg), the drug maker said in a regulatory filing. Enzalutamide tablets are androgen receptor inhibitors indicated for the treatment of patients with castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer.
3 days ago · The US health regulator inspected Zydus Lifesciences’ transdermal patch manufacturing facility in Pharmez, Ahmedabad, between July 15 and July 19, the company stated in an exchange filing. The USFDA has now issued an EIR for the facility, classifying it as ‘Voluntary Action Indicated’ (VAI). Shares of Zydus Lifesciences Ltd gained nearly ...
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, [3] is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacturing of generic drugs.
Zydus Lifesciences Limited Stock Price Today, Live NSE Share Price: Get the latest Zydus Lifesciences Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
We see and experience this each day at work, where more than 26000 Zydans across geographies are innovating, engaging, creating and delivering therapies that serve patient needs around the world and providing significant value to stakeholders. Follow Us. BOARD OF DIRECTORS. Pankaj R. Patel. Chairman. Dr.Sharvil P. Patel. Managing Director
Get the latest Zydus Lifesciences Ltd (ZYDUSLIFE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...
Feb 9, 2024 · Indian generic drugmaker Zydus Lifesciences reported a bigger-than-expected rise in third-quarter profit on Friday, driven by strong sales in its domestic and overseas markets.
